Breaking News, Promotions & Moves

XyloCor Therapeutics Names New President and CEO

John Tucker brings more than 20 years of leadership experience in the biotechnology and life sciences industries.

Author Image

By: Charlie Sternberg

Associate Editor

XyloCor Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing innovative therapies for cardiovascular disease, has appointed John Tucker as President and Chief Executive Officer (CEO), effective immediately. Tucker brings more than 20 years of leadership experience in the biotechnology and life sciences industries, with a proven track record of advancing clinical programs, building high-performing teams, and driving strategic growth. He succeeds the Company’s cur...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters